An update on ATP synthase inhibitors: A unique target for drug development in M. tuberculosis.

Kelam, Lakshmi Mounika; Wani, Mushtaq Ahmad; Dhaked, Devendra K

Kelam, Lakshmi Mounika; Wani, Mushtaq Ahmad; Dhaked, Devendra K.

Afiliação

Kelam LM; Department of Pharmacoinformatics, National Institute of Pharmaceutical Education and Research (NIPER)-Kolkata, Chunilal Bhawan, 168 Maniktala Main Road, Kolkata, 700054, West Bengal, India.
Wani MA; Department of Pharmacoinformatics, National Institute of Pharmaceutical Education and Research (NIPER)-Kolkata, Chunilal Bhawan, 168 Maniktala Main Road, Kolkata, 700054, West Bengal, India.
Dhaked DK; Department of Pharmacoinformatics, National Institute of Pharmaceutical Education and Research (NIPER)-Kolkata, Chunilal Bhawan, 168 Maniktala Main Road, Kolkata, 700054, West Bengal, India. Electronic address: devendra.bcp@gmail.com.

Prog Biophys Mol Biol ; 180-181: 87-104, 2023.

Article em En | MEDLINE | ID: mdl-37105260

Assuntos

Mycobacterium tuberculosis; Tuberculose; Humanos; Antituberculosos/farmacologia; Antituberculosos/metabolismo; Mycobacterium tuberculosis/metabolismo; Trifosfato de Adenosina/metabolismo; Tuberculose/tratamento farmacológico; Desenvolvimento de Medicamentos

Palavras-chave

ATP synthase; ATP synthase Inhibitors; Bedaquiline; F(1)F(o) ATP synthase; Oxidative phosphorylation pathway; Proton motive force

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose / Mycobacterium tuberculosis Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google